Horizon Space Acquisition I Corp.
Status: Live Deal
U=S+W+R
W=S@11.50
R=S/10
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Dec 22, 2022 |
| CEO | Mingyu (Michael) Li |
| Left Lead | Network 1 Financial Securities |
| IPO Cash in Trust | 101.8% |
| SPAC Tenor | 9 + 6 + 9 + 10 + 6 + 2 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | ArcheNova Biotech Corp. |
| Deal Announced | Oct 13, 2026 |
| Deal Size, $M | $2,000.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Apr 20, 2026 |
HSPOF
HSPUF
HSPWF
HSPRF
| Price | $12.29 |
|---|---|
| Last closing price | $12.29 |
| H/L, today | $12.29 / $12.29 |
| Volume, today | 19 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.